01 maj: Verdens måske fineste skjorter kommer til Danmark
07 maj: 10 aktier til den langsigtede portefølje
01-05-2012 17:24:00

UPDATE: DuPont Buys Full Ownership Of Solae Venture From Partner Bunge

Relateret indhold

--DuPont buys Bunge's 28% stake in Solae venture

--DuPont pays Bunge $440 million

--Bunge to invest proceeds in core businesses

(Updates to include financial terms of deal in 1st paragraph, Bunge earnings in the 6th paragraph and comment by CFO in the 7th paragraph)

DOW JONES NEWSWIRES

E.I. DuPont de Nemours & Co. paid Bunge Ltd. (BG) about $440 million to acquire full ownership of Solae LLC, their soy-based ingredients venture, as DuPont looks to expand its position in the food ingredients market.

DuPont previously owned 72% of the venture while Bunge owned the remaining 28%.

The companies formed the venture in early 2003 to produce and distribute specialty food ingredients. At that time, DuPont estimated initial global revenue from Solae to exceed $800 million annually. In exchange for its specialty-food-ingredients businesses in 2003, Bunge was to receive the 28% interest in the venture plus an estimated $260 million, which was funded by joint-venture debt.

DuPont said its long-term segment financial targets are to post a 7% to 9% compound annual growth rate for sales and to expand pretax earnings margins 12% to 14%. With full ownership of Solae, DuPont expects to reach the upper end of its margin targets with planned synergies.

The chemicals giant last month reported its first-quarter profit rose 4% as higher pricing and a jump in sales of agricultural products contributed to a 12% sales increase.

Meanwhile, Bunge reported last week its first-quarter earnings fell by a greater-than-expected 60% as weak prices for fertilizer and its sugar-based ethanol hurt margins, though revenue grew 10%.

The Solae deal allows Bunge "to redeploy capital into our strategic, core businesses," said Chief Financial Officer Drew Burke in a statement Tuesday.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

(END) Dow Jones Newswires

May 01, 2012 11:24 ET (15:24 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Nye digitale betalingsløsninger bryder frem

25-09-2017 08:45:00
Sponsoreret indhold:Af Jens Damgaard, Country Manager, Visa DenmarkEfter 20 år, hvor danskerne har taget imod ganske mange nye løsninger indenfor elektroniske/digitale betalinger, går udviklingen nu endnu hurtigere, og det gør Danmark til et af de mest avancerede betalingsmarkeder i Europa. Avanceret, fordi danskerne er parat til at bruge næsten enhver tænkelig mobil enhed til at betale med.Buti..

Novo: Fiasp godkendt i USA

29-09-2017 16:20:48
De amerikanske sundhedsmyndigheder, FDA, har godkendt Fiasp (hurtigtvirkende insulin aspart), en ny hurtigtvirkende måltidsinsulin, til behandling af voksne med diabetes.Det oplyser Novo Nordisk.FDA's beslutning kommer, efter at kliniske studier har dokumenteret, at Fiasp giver fordele for mennesker, der har behov for en forbedret generel blodsukkerregulering.- Vi er meget glade for, at Fiasp nu o..

Atlantic Petroleum: Direktør fratræder 1. december

29-09-2017 14:02:37
Topchefen for Atlantic Petroleum, der er noteret i Norge og København, direktør Ben Arabo, har opsagt sit job for at tiltræde et andet job på Færøerne.Det oplyser selskabet.Han vil dog blive hos Atlantic Petroleum til 1. december./ritzau/FINANSClaus Mikkelsen +45 33 30 03 35 Ritzau Finans, E-mail: finans@ritzau.dk , www.ritzaufinans.dk

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Novo og Genmab i fokus på afventende dag
2
Aktier/åbning: Novo stiger op til ekspertdom - Genmab fortsætter ned
3
Novo: Mulig milliardsællerts skæbne er i eksperternes hænder - GENT
4
Aktier/middag: Tunge Novo trækker C20 ud i overhalingsbanen
5
ISS får sin største kontrakt nogensinde på 33 milliarder over ti år

Relaterede aktiekurser

Bunge Limited 70,87 -0,5% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. oktober 2017 20:26:56
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171017.1 - EUROWEB7 - 2017-10-18 20:26:56 - 2017-10-18 20:26:56 - 1 - Website: OKAY